Groundbreaking experiment from Turkish scientist Aziz Sancar

A research team led by Nobel Prize in Chemistry laureate Prof. Dr. Aziz Sancar has reached remarkable results in a study on glioblastoma, one of the most aggressive and deadly types of brain cancer.

In experiments conducted on mice, it was determined that glioblastoma tumors were completely eradicated. It was stated that the necessary authorization processes for the study to be applied to humans are continuing.

NEW TREATMENT METHOD FOR GLIOBLASTOMA

Within the scope of the research, a molecule called EdU, which targets cell division, was administered together with Temozolomide (TMZ), a standard chemotherapy drug currently in use. It was observed that this combination completely eliminated tumor tissue in mice.

The results of the experiment noted that the treatment targeted only cancerous cells and did not cause any damage to healthy brain tissue.

LONG-TERM SURVIVAL OBSERVED IN MICE

In the study, it was shared that the mice treated survived for a long time and the disease did not recur. The researchers reported that the data obtained points to an important milestone in the treatment of glioblastoma.

STUDY PUBLISHED IN PNAS

The results of the experimental treatment were detailed in the research published in PNAS (Proceedings of the National Academy of Sciences), the scientific journal of the National Academy of Sciences, of which Aziz Sancar is a member.

The scientific publication emphasized that the method is safe and that healthy tissues are protected while targeting cancerous cells.

PROCESS FOR HUMAN TRIALS CONTINUES

In statements made by the research team, it was indicated that following the findings obtained, the necessary authorization and evaluation processes to move to clinical trials in humans are ongoing.

It was stated that the study could open the door to a new approach in the treatment of glioblastoma.

News Source: 12punto